IndraLab

Statements



reach
"A study published by our group showed that amodiaquine, an FDA-approved drug used against malaria, inhibited transcription of rDNA and enhanced proteasomal degradation of POLR1A followed by p53 stabilization [86]."

reach
"Herein, we report a novel activity of the FDA approved antimalarial drug amodiaquine which inhibits rRNA transcription, a rate limiting step for ribosome biogenesis, in a dose dependent manner."

reach
"An illustrative recent example is the discovery that the antimalarial drug amodiaquine inhibits rDNA transcription through a mechanism similar to a well-established inhibitor of RiBi, BMH-21 [ 80 ]."